Evommune, Inc.

EVMN
$14.22 (- $0.03 - 0.21%)
Last updated: 2026-08-18 15:37 UTC
EVMN Metrics
Exchange
🇺🇸 NYSE XNYS
New York Stock Exchange, Inc.United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS30054Y1073
CUSIP30054Y107
Market Price14.22
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-2.09
Market Cap$556.2M
Book Value-117.78
Price to Book-0.15
BetaN/A
52w High24.03
52w Low13.88
Next Earnings DateN/A

Evommune, Inc. trades under ticker EVMN on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US30054Y1073, CUSIP 30054Y107. Also searched as Evommune.

Related researchEVMN stock priceEVMN share price30054Y107Evommune stockEvommune share price
About the Company
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. It develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products includes EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
Price History